Diabetes vaccine stumbles at second hurdle
Sunday 03 July 2011
An experimental vaccine to prevent progression of Type 1 diabetes failed at the second step of the three-phase trial process, doctors said on Monday in a study reported online by The Lancet.
The vaccine sought to protect insulin-producing beta cells in the pancreas from the body's immune system.
Its formula is based on an enzyme called glutamic acid decarboxylase (GAD), which the over-sensitised immune system targets - and in doing so destroys the precious beta cells.
The idea was that by vaccinating patients with GAD, this would teach the immune system's T cells to tolerate the enzyme.
The trial was carried out on 145 patients aged three to 45 years living in the United States and Canada who had been diagnosed with Type 1 diabetes within the previous three months.
The volunteers were given either the vaccine; the vaccine plus a standard immune-system booster; or just the booster alone.
Patients in all three groups experienced similar progression in the disease, with no difference among them in side effects.
The paper, led by Jay Skyler of the University of Miami Miller School of Medicine, was presented at a conference of the American Diabetes Association in San Diego, California.
Despite the setback, the investigators called for more research to see if the formula might work when administered sooner or as part of a combination therapy.
The number of adults with diabetes worldwide has more than doubled since 1980, with almost 350 million now affected, according to data reported earlier at the conference.
Diabetes is caused by poor blood sugar control and can lead to heart disease and stroke and damage the kidneys, nerves and eyes.
High blood sugar levels and diabetes kill three million people across the world each year.
The surge is attributed to longer lifespan and excess weight, especially among women.
Type 1, a condition that affects about five to 10 percent of people with diabetes, was previously known as juvenile diabetes because it typically shows up in children or young adults. Patients have to take daily insulin shots for the rest of their lives and follow dietary guidelines and exercise.
In Type 2 diabetes, previously known as adult-onset diabetes, either the body does not produce enough insulin or cells are resistant to the hormone. The condition is managed by diet, exercise as well as insulin shots if need be.
arts + entsThere were towering ideas, some scintillating performances and revelatory grooves... our writers pick out their personal highlights
elephant appealThe first 23 lots in our charity auction have now gone. But there are 22 more still up for grabs
elephant appealPrince William signs up for our charity appeal
peoplePrepare to be entranced by worms as the molecular biologist gets ready to give the Royal Institution science lectures
elephant appealSo says man jailed for cutting off dead elephant's tusks
booksWe examine the best titles for teens
voicesPeople moan that Christmas is too commercial, the spirit lost. But it is a time to over-indulge, and always has been, says DJ Taylor
scienceResearchers teach border collie to understand sentences using more than 1,000 words
booksA Christmas story in six parts
travelWill high-value tourism help the workshops of this Renaissance city?
food + drinkA trifle without custard? Surely not! Nonsense – and here’s three to finish your festive meal that prove it
Geoffrey Macnab does not like the comedian's big screen debut
Life & Style blogs
Drunken assaults, drug abuse, spiked drinks – and a young couple in a pine tree: Not a very merry Christmas for the paramedics
The 10 Best Scotch Whiskies
America's 'virgin births'? One in 200 mothers 'became pregnant without having sex'
GTA 5: Rockstar bans gamers stealing in-game money worth millions
Winter Solstice 2013: Shortest day of the year marked with 'knitted' Google Doodle
- 1 Top PR exec Justine Sacco under fire for sending racist tweet before flying to Africa
- 2 French pub fined €9,000 after customers returned empties to bar - because it's 'undeclared labour'
- 3 Sun will 'flip upside down' within weeks, says Nasa
- 4 The publisher who played with fire: the battle for control of Larsson's £30m legacy
- 5 Police seize possessions of rough sleepers in crackdown on homelessness
- < Previous
- Next >
£40000 - £65000 per annum + Benefits : Harrington Starr: C#.NET Developer (WPF...
£45000 - £65000 per annum + London: Harrington Starr: Senior Automation QA Eng...
Negotiable: Capita Education Resourcing Permanent Team: Year 6 Teacher - Gilli...
Negotiable: Capita Education Resourcing Permanent Team: Teacher of English - S...